Early salvage therapy for prostate cancer relapse after surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests giving early salvage radiotherapy (a type of radiation) to men whose PSA rises after prostate removal, but before it shows up on scans. It aims to see if starting treatment early, based on molecular markers, is more effective than waiting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have had your prostate removed (radical prostatectomy) for prostate cancer.
- After surgery, your PSA went down to very low levels and then rose again (biochemical relapse).
- You have not had hormone therapy before or after surgery.
- You have no evidence of cancer spread to lymph nodes or distant organs.
- You are generally healthy and able to participate (ECOG 0-1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well salvage radiation therapy works for prostate cancer that has come back after surgery. It looks at whether adding hormone therapy based on PSA response improves outcomes.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial studies whether a targeted scan (PSMA PET/CT) can help doctors choose the best “salvage” radiation treatment when prostate cancer comes back by PSA blood tests after surgery. It may help some people avoid under- or over-treating the areas where the cancer is returning.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
This trial compares two different radiation schedules to treat prostate cancer that returned based on rising PSA blood tests after prostatectomy (prostate removal). If you qualify, it may help you and your team choose a radiation approach with the goal of controlling PSA relapse.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.